IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?

Chia Siang Kow; Abdullah Faiz Zaihan; Dinesh Sangarran Ramachandram; Syed Shahzad Hasan

doi:10.1016/j.cyto.2021.155730

IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?

Chia Siang Kow, Abdullah Faiz Zaihan, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Article number	155730
Number of pages	2
Journal	Cytokine
Volume	149
Early online date	5 Oct 2021
DOIs	https://doi.org/10.1016/j.cyto.2021.155730
Publication status	Published - 1 Jan 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.cyto.2021.155730Licence: Unspecified

IL_6_antagonist_to_replace_corticosteroids_AAM (1)Accepted author manuscript, 375 KBLicence: CC BY-NC-ND

Cite this

@article{4e1e099f1d1a4a32b27f84070f6f0d19,

title = "IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?",

keywords = "Corticosteroid, COVID-19, IL-6 antagonist, Sarilumab, Tocilizumab",

author = "Kow, \{Chia Siang\} and Zaihan, \{Abdullah Faiz\} and Ramachandram, \{Dinesh Sangarran\} and Hasan, \{Syed Shahzad\}",

year = "2022",

month = jan,

day = "1",

doi = "10.1016/j.cyto.2021.155730",

language = "English",

volume = "149",

journal = "Cytokine",